Vir Biotechnology Inc (NASDAQ: VIR) is 64.85% higher on its value in year-to-date trading and has touched a low of $6.56 and a high of $14.45 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The VIR stock was last observed hovering at around $12.48 in the last trading session, with the day’s loss setting it -0.38%.
Currently trading at $12.10, the stock is 52.28% and 48.04% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.46 million and changing -3.04% at the moment leaves the stock 38.27% off its SMA200. VIR registered 18.86% gain for a year compared to 6-month loss of 32.10%. The firm has a 50-day simple moving average (SMA 50) of $8.1737 and a 200-day simple moving average (SMA200) of $8.75115.
The stock witnessed a 38.76% gain in the last 1 month and extending the period to 3 months gives it a 65.08%, and is 66.44% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.20% over the week and 6.55% over the month.
Vir Biotechnology Inc (VIR) has around 587 employees, a market worth around $1.67B and $78.62M in sales. Profit margin for the company is -678.40%. Distance from 52-week low is 84.45% and -16.26% from its 52-week high. The company has generated returns on investments over the last 12 months (-39.98%).
with sales reaching $9.37M over the same period.The EPS is expected to grow by 15.42% this year, but quarterly earnings will post -12.77% year-over-year. Quarterly sales are estimated to shrink -44.19% in year-over-year returns.
Vir Biotechnology Inc (VIR) Top Institutional Holders
291.0 institutions hold shares in Vir Biotechnology Inc (VIR), with institutional investors hold 84.12% of the company’s shares. The shares outstanding are 136.71M, and float is at 87.71M with Short Float at 7.47%. Institutions hold 74.11% of the Float.
The top institutional shareholder in the company is SB INVESTMENT ADVISERS (UK) LTD with over 16.68 million shares valued at $148.49 million. The investor’s holdings represent 12.3329% of the VIR Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 16.43 million shares valued at $146.26 million to account for 12.1482 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 12.85 million shares representing 9.4982% and valued at over $114.36 million, while STATE STREET CORP holds 3.7662 of the shares totaling 5.09 million with a market value of $45.34 million.
Vir Biotechnology Inc (VIR) Insider Activity
The most recent transaction is an insider sale by SATO VICKI L, the company’s Director. SEC filings show that SATO VICKI L sold 10,960 shares of the company’s common stock on Jan 08 ’25 at a price of $12.52 per share for a total of $0.14 million. Following the sale, the insider now owns 1.31 million shares.
Still, SEC filings show that on Dec 02 ’24, de Verneuil Vanina (EVP and General Counsel) disposed off 76 shares at an average price of $8.22 for $625.0. The insider now directly holds 56,973 shares of Vir Biotechnology Inc (VIR).
